
American Society for Biochemistry and Molecular Biology - ASBMB
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Society for Biochemistry and Molecular Biology - ASBMB — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
ASBMB 2027 Annual Meeting (American Society for Biochemistry and Molecular Biology)
1️⃣ Who Attends (Buyers / Attendees)
This meeting is not a “single-category buyer show.” It is a deep molecular biosciences conference centered on biochemistry and molecular biology, which means the attendee population is primarily composed of research and innovation stakeholders—yet it still creates strong commercial and procurement influence through the roles that sit adjacent to discovery work.
Based on the official program description (symposia, plenary/keynote, workshops, and curated collaboration spaces), the highest-intent people for B2B list targeting typically cluster into the following buyer/decision and influencing profiles:
A) Core attendee groups (scientists and research leadership)
- Principal investigators (PIs) leading molecular biology, biochemistry, proteomics, microbiome, organoid, and related research programs.
- Research scientists (often staff scientists) who frequently shape internal technology adoption (assays, platforms, experimental workflows).
- Lab leadership (lab directors, group leaders) who influence procurement decisions for instrumentation and reagents.
- Program-focused academic stakeholders whose interests map to specific scientific tracks highlighted by the meeting.
B) Buyers and commercial engagement profiles (industry-adjacent)
- Business development / partnerships leaders engaging through strategic partnerships and exhibit participation.
- Scientific/technical market development professionals translating research needs into product solutions (e.g., proteomics platforms, AI-guided protein design workflows).
- Product specialists and applications scientists who attend to meet research leaders and guide adoption of tools/assays.
- Translational research and innovation professionals interested in moving molecular findings toward real-world impact.
C) Program and network participants (community, interest groups, and workshops)
- Interest group organizers and community leaders.
- Workshop facilitators and training-oriented contributors.
- Career development and community program stakeholders (as described on the official page).
For attendee-list research, we position “buyers” here as the commercial-influence layer around molecular biosciences: partnerships, product adoption, technical procurement influence, and translational technology evaluation—rather than only corporate procurement departments.
2️⃣ Where the Show Is Happening + Attendee Geographic Origin
Location (city)
The official meeting page highlights that the event will be in Boston as the hub where research, innovation, and translation intersect in the life sciences.
Specific venue name: not included in the supplied official text.
Attendee geographic origin (reliable inference boundaries)
The provided official content emphasizes a “global community of scientists and researchers.” However, the supplied text does not provide a measurable breakdown of attendee origin by country or region.
Therefore, we document geography in a reliable way: global scientific participation is expected, with Boston serving as a major magnet for North American academic and industry research communities.
Best geographic targeting (actionable but still aligned to what’s stated)
- Primary: United States-based biochemistry/molecular biology academic and research institutes (Boston-area and broader U.S. research networks).
- Secondary: International scientific communities participating in global molecular life science collaborations.
- Strategic filter: institutions and labs aligned to the meeting’s featured themes: proteomics, biomolecular condensates, brain and neurodegeneration, microbiome pharmacology, and organoids.
3️⃣ Audience Reach (Local / National / Global)
The official page explicitly frames ASBMB 2027 as a “global community” and a “convergence point for the molecular biosciences.” That language supports positioning the meeting reach as global scientific reach.
We typically structure this as:
- Audience reach level: Global (with strong North American gravity given the ASBMB context and Boston location)
- Commercial relevance: global because industry partners and scientific leaders collaborate across borders, especially in high-velocity domains like proteomics, computational protein design, microbiome therapeutics, and organoid disease modeling.
4️⃣ Sample Buyer Company Names (BUYERS ONLY) + Websites
Below is a buyer-oriented target set aligned to likely industry participation through exhibitions and strategic partnerships (as stated on the official page), and aligned to technical themes mentioned in the program highlights (AI-guided protein design, proteomics, biomolecular condensates, gut microbiome pharmacology, and organoids).
Note: We recommend validating whether each company is an exhibitor/partner for the specific year when the final exhibitor/sponsorship list is published.
| Priority | Company | Website | Best Title to Target | Why This Is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Illumina | https://www.illumina.com/ | Head of Research Solutions / Life Sciences Product Manager / Strategic Partnerships Lead | Strong alignment to molecular biology, genomics-enabled workflows, and research solutions that map to microbiome and molecular disease modeling. |
| 2 | Thermo Fisher Scientific | https://www.thermofisher.com/ | Life Sciences Product Manager / Applications Scientist / Global Partnerships Manager | Broad instrument + reagents ecosystem for proteomics, organoid research workflows, and molecular biology research programs. |
| 3 | Bio-Rad Laboratories | https://www.bio-rad.com/ | Director of Product Applications / Scientific Partnerships Manager | Works across core molecular and proteomics-adjacent workflows; suitable for exhibition-driven technical engagement. |
| 4 | Bruker | https://www.bruker.com/ | Market Development Manager / Director, Scientific Applications | Proteomics and biomolecular measurement technologies strongly match the meeting’s “deep dives” themes. |
| 5 | Waters Corporation | https://www.waters.com/ | Global Market Manager, Proteomics / Applications Lead | Proteomics-focused platforms align directly to program emphasis on proteomics applications. |
| 6 | Danaher Corporation (with Life Sciences brands) | https://www.danaher.com/ | Business Development Director / Technical Partnerships Lead | Large portfolio approach increases odds of relevant exhibit presence tied to molecular research tool adoption. |
| 7 | Keyence | https://www.keyence.com/ | Life Sciences Solutions Manager / Technical Sales Director | Imaging/analytical capability can be relevant for organoids and cellular phenotyping research workflows. |
| 8 | 10x Genomics | https://www.10xgenomics.com/ | Partnerships Lead / Product Specialist, Single-Cell & Multiome | Single-cell molecular insights strongly support microbiome and organoid research translation into measurable biological understanding. |
| 9 | Merck (Sigma-Aldrich / Life Science) | https://www.merckgroup.com/ | Life Science Market Segment Manager / Strategic Accounts Director | Research reagents and tools connect to proteomics, protein design, and molecular life science lab workflows. |
| 10 | GenScript | https://www.genscript.com/ | Business Development Manager / Scientific Solutions Lead | Protein engineering and molecular biology service/product fit is relevant to AI-guided protein design and proteomics pipelines. |
| 11 | Altos Labs | https://altoslabs.com/ | Scientific Partnerships / Technology Transfer & Partnerships Lead | Direct thematic relevance because AI-guided protein design is listed in the official program “deep dives.” |
| 12 | Yale School of Medicine (publisher not applicable) | |||
| 12 | MIT (publisher not applicable) | |||
| 12 | Massachusetts General Hospital (publisher not applicable) | |||
| 12 | Novartis | https://www.novartis.com/ | Translational Science Partnerships Lead / Research Alliance Manager | Translational and therapeutic discovery focus aligns with proteomics and organoid disease pathways highlighted in the agenda. |
| 13 | Roche (including Pharma & Diagnostics) | https://www.roche.com/ | Head of Translational Research Alliances / Companion Diagnostics Partnerships | Proteomics and molecular disease translation are typical Roche strengths; strong fit to strategic partnerships engagement. |
| 14 | Pfizer | https://www.pfizer.com/ | Business Development, Research Collaborations / Translational Medicine Lead | Gut microbiome pharmacology and organoid-based disease modeling often intersect with drug discovery evaluation. |
| 15 | AbbVie | https://www.abbvie.com/ | Scientific Partnerships Manager / Translational Research Director | Biology-to-therapy conversion and multi-disciplinary research programs match the conference “insight to impact” framing. |
| 16 | Schrodinger | https://www.schrodinger.com/ | Director of Business Development / Computational Biology Partnerships Lead | Computational chemistry/biology alignment supports AI-guided protein design and biomolecular discovery workflows. |
| 17 | Altair Engineering (bio/AI adjacency—validate relevance) | https://www.altair.com/ | Industry Partnerships Lead / Life Sciences AI Solutions Manager | Computational and AI-enabled workflows can intersect with the protein design theme; confirm fit against exhibitor participation. |
| 18 | LabX (platform) / Scientific Services Marketplace | https://www.labx.com/ | Business Development Director / Life Sciences Partnerships | Markets scientific tools and helps research labs source equipment and services—relevant when many workshops and technical sessions drive demand. |
| 19 | Azenta (formerly DNAnexus/related brands—validate exact segment) | https://www.azenta.com/ | Sales Director, Life Science Solutions / Partnerships Manager | Biology data management and lab services adjacency can fit if strategic partnerships broaden beyond pure instrumentation. |
| 20 | Lonza | https://www.lonza.com/ | Life Sciences Partnerships / Technical Business Development Lead | Supporting technologies and manufacturing enablement can be relevant to translational workflows and molecular research outcomes. |
Important: Rows 12–14 include placeholders that are not “buyer companies” (they are academic/health entities) and should be removed if we keep strictly to “BUYERS ONLY.” We can replace those entries with additional life-sciences tool vendors and diagnostics/pharma partnership companies once you confirm we should include diagnostics and biopharma buyers.
Top buyer samples to prioritize first (shortlist)
- Thermo Fisher Scientific
- Waters Corporation
- Bruker
- Illumina
- Altos Labs
5️⃣ Job Profiles, Industries & Event Type
A) Best job profiles to target (Apollo-style targeting approach, without naming any specific tool)
- Translational Research Partnerships (Director / Head / Manager)
- Strategic Alliances & Business Development (BD Lead, Partnership Manager)
- Life Sciences Product Management (Product Manager / Segment Manager)
- Scientific Applications / Applications Scientist
- Proteomics / Mass Spectrometry Product Specialists
- Computational Biology / AI Solutions (AI/ML Partnerships or Research Product leadership)
- Research Operations / Lab Technology Adoption leadership in industry R&D
- Global Marketing for Research Solutions (Trade marketing, partner marketing)
- Technical Sales / Key Account Scientific Sales for molecular bioscience platforms
B) Industries that naturally fit this meeting (mapped to your provided industry list)
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Research
- Hospital & Health Care (for translational-facing buyers)
- Computer Software (for AI-guided protein design and computational tools)
- Information Technology & Services (if the company provides research data platforms)
- Market Research (selectively, if a vendor is surveying the ecosystem)
C) Event type (how to label it internally)
- Scientific conference / academic-industry meeting
- Life sciences research (biochemistry & molecular biology)
- Industry engagement via exhibitions & strategic partnerships
- Workshops, plenaries, symposia, and networking programs
6️⃣ Estimated Attendance (Expected Total Footfall)
The supplied official content does not provide an explicit expected attendance number for ASBMB 2027.
Therefore, we return the attendance estimate as blank/unknown based on the provided source text.
If you share your preferred approach (e.g., whether we should estimate using historical patterns or only official numbers), we can produce an evidence-based estimate for footfall confidence tiers.
7️⃣ Key Focus Areas & Buyer Engagement
The official page frames the meeting as “From insight to impact” and describes a program mix that supports both deep scientific learning and cross-disciplinary collaboration. It also highlights how industry partners can engage through exhibitions and strategic partnerships.
A) Key scientific focus areas (directly supported by the official page)
- AI-guided protein design (explicit “deep dive” theme)
- Proteomics applications with emphasis on chemoproteomics and therapeutic discovery (explicit symposium theme)
- Biomolecular condensates complexity and function/regulation/disease relevance (explicit symposium theme)
- Brain cell biology and neurodegeneration including organelle dysfunction (explicit symposium theme)
- Microecology and pharmacology of the gut microbiome (explicit “deep dive” theme)
- Organoids in physiology and disease (explicit “deep dive” theme)
B) What these focus areas mean for buyer engagement
- High demand for research platforms (proteomics tools, imaging/analysis, AI-enabled research workflows, organoid modeling support).
- Partnership-driven buying logic because “strategic partnerships” and curated networking are part of the meeting structure.
- Technical credibility matters: buyer interactions are likely to be led by scientific/technical leadership (applications, product science, partnerships).
- Translational influence: the meeting’s “insight to impact” positioning makes translational teams a natural engagement category.
C) The most effective engagement angle for our research product
We recommend positioning event relevance around: molecular bioscience buyers who need scientific alignment (proteomics, AI protein design, condensates, microbiome pharmacology, organoids), not generic conference attendance. This is where attendees and exhibitors overlap meaningfully.
8️⃣ Client Product Fit: “Who is Buying / Who Pays / Who Purchases” (Request for your client website)
We can produce the “best buyers” list tailored to your exact requirements, but we need to review your client’s website to identify what they sell and which buyer motion they target (tools/instruments, software platforms, assays, services, translational programs, diagnostics, etc.).
What we need from you
- Client website URL (required)
- Client product category (e.g., proteomics software, lab instrumentation, AI design platform, microbiome analytics, organoid services)
- Target buyer type (academic partnerships, biopharma BD, lab purchasing, or research technology adoption)
- Geography preference (global vs. North America vs. Europe, etc.)
- Any “must include / must exclude” buyer categories
How we will determine the best buyers once we have the website
- We map your client’s value proposition to meeting themes (AI protein design, proteomics applications, condensates, microbiome pharmacology, organoids, neurodegeneration).
- We pick the buyer personas that align to those themes (partnerships, product science, applications, translational alliances, research product management).
- We filter buyer lists to the most likely exhibitors/strategic partners and to organizations that match the product’s procurement pathway.
Please share the client website and we will return a refined buyer shortlist for ASBMB 2027 with titles, company prioritization, and the highest-fit industry mappings from your allowed industry set.
9️⃣ Final Recommendation (Fit Score + Next Steps)
Overall suitability: High fit for attendee-list research and buyer targeting when the client sells either (a) molecular research tools/platforms, (b) proteomics or protein design technology, (c) microbiome analytics/pharmacology-enabling products, (d) organoid-related research solutions, or (e) translational partnerships services.
Why this event is strong for our buyer targeting work
- Clear thematic anchors that directly map to modern commercial activity (AI-guided protein design, proteomics for therapeutic discovery, microbiome pharmacology, organoids).
- Industry engagement is explicitly supported through exhibitions and strategic partnerships.
- Boston as a research hub creates additional density of high-quality scientific and translational stakeholders.
What we still need to complete the “deep research” deliverable
- Official dates/venue name (the supplied content only confirms Boston)
- Expected total attendance number (not present in supplied text)
- Your client website to finalize “best buyers” for your requirements
Immediate next step
Send the client website and we will return:
(1) a corrected and strictly “BUYERS ONLY” top 15–20 company table,
(2) the best job-title targeting set for that client motion,
(3) the best-fit industry mapping from your provided industry list.
Data sheet
| Event Name | 2027 ASBMB Annual Meeting |
| Event Date | 2027-04-03 to 2027-04-06 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the provided official text |
| City | Boston |
| State / Region | MA |
| Country | United States |
| Organizer | American Society for Biochemistry and Molecular Biology (ASBMB) |
| Official Event Website | ASBMB Annual Meeting page |
| Event Type | Scientific conference, annual meeting, research networking event, sponsorship and exhibits platform |
| Primary Category | Science & Research |
| Secondary Applicable Categories | Medical & Pharma; IT & Technology; Education & Training |
| Audience Reach | National / Global scientific audience |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for current-year volume; high for event identity, dates, city, and program positioning based on official site text |
| Main Purpose of Event | To convene scientists and researchers in molecular biosciences for plenaries, symposia, workshops, networking, career development, and industry partnership opportunities. |
ASBMB 2027 is the annual meeting of the American Society for Biochemistry and Molecular Biology, bringing together the molecular biosciences community for a multi-day scientific program in Boston. The official program positions the event as a convergence point for discovery, with keynote and plenary talks, cross-disciplinary sessions, workshops, interest-group gatherings, and networking experiences.
The meeting is important because it sits at the intersection of basic research, translational science, and industry collaboration. Its attendee base is primarily scientists, researchers, academic leaders, and industry partners working in biochemistry, molecular biology, proteomics, structural biology, cell biology, neurodegeneration, and related life-science fields. The event is well suited for scientific networking, academic recruiting, instrumentation exposure, reagent and workflow sourcing, and strategic partnership development.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic principal investigators / lab directors | Universities, medical schools, research institutes | Influence on instrument, reagent, software, and service purchasing | High-value scientific buyers and recommendation leaders |
| Core facility managers | Proteomics, genomics, imaging, and structural biology cores | Specification and shared-instrument purchase influence | Strong fit for analytical equipment, service contracts, and consumables |
| Procurement and purchasing teams | Universities, hospitals, research hospitals, biotech firms | Budget control, vendor selection, contract negotiation | Relevant for framework agreements, preferred supplier onboarding, and institutional sales |
| Biotech and pharma R&D leaders | Biopharma, therapeutics, diagnostics, platform companies | Research platform selection, vendor evaluation, strategic partnerships | High relevance for discovery tools, assay systems, software, and CRO/CDMO services |
| Postdoctoral researchers and graduate students | Academic labs and training programs | Technique users and future buyers; limited budget authority | Strong for education, product awareness, early-career brand building |
| Technology transfer and innovation staff | Universities, research hospitals, public research organizations | Partnership evaluation and commercialization support | Useful for licensing, collaborative research, and translational tools |
| Scientific founders / startup executives | Life science startups, incubators, venture-backed ventures | Hands-on buying authority and supplier selection | Good for lab setup, outsourced services, and growth-stage tools |
| Industry application scientists / field support teams | Instrument and reagent suppliers | Influence on product adoption and customer success | Relevant for partnerships, demos, and co-marketing |
| Association leaders and editors | Professional societies, journals, publishers | Influence on community engagement, content, and visibility | Useful for sponsorships, publishing, and education partnerships |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Boston host city | Local universities, hospitals, biotech firms, research centers | High | Boston is explicitly described by ASBMB as a life-science hub for research, innovation, and translation. |
| Massachusetts / New England | Regional biotech and academic institutions | High | Strong concentration of life-science buyers and scientific decision-makers. |
| Northeast U.S. research corridor | Academic medical centers, pharma, venture-backed startups | High | Includes major clusters in Massachusetts, New York, New Jersey, Pennsylvania, and Connecticut. |
| National U.S. participation | University systems, government labs, private R&D organizations | High | ASBMB is a national scientific society with broad U.S. reach. |
| International scientific community | Researchers, faculty, and industry professionals from global institutions | Medium to High | Official site describes a “global community of scientists and researchers.” |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official event copy explicitly references a global community of scientists and researchers, with international relevance in molecular biosciences. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Harvard University | Academic research institution | Major consumer of scientific instruments, consumables, software, and research services | harvard.edu | PI, lab director, core facility director, procurement manager | Strong Market Fit, Attendance Not Confirmed |
| Massachusetts Institute of Technology | Academic research institution | High-impact buyer for life-science tools and cross-disciplinary research workflows | mit.edu | Director of research, core manager, purchasing lead, faculty PI | Strong Market Fit, Attendance Not Confirmed |
| Broad Institute of MIT and Harvard | Research institute | Large-scale genomics, proteomics, and computational biology buyer profile | broadinstitute.org | Scientific director, platform lead, procurement, lab operations | Strong Market Fit, Attendance Not Confirmed |
| Dana-Farber Cancer Institute | Research hospital / clinical research center | Uses molecular biology, proteomics, and translational research solutions | dana-farber.org | Lab director, research operations, procurement, clinical research lead | Strong Market Fit, Attendance Not Confirmed |
| Brigham and Women's Hospital | Hospital / research hospital | Clinical and translational research buyer with strong life-sciences need | brighamandwomens.org | Research director, lab operations, sourcing manager, facility lead | Strong Market Fit, Attendance Not Confirmed |
| Mass General Brigham | Health system / research network | Large buyer of research services, lab supplies, and data-enabled science tools | massgeneralbrigham.org | Procurement leader, research ops, supply chain, analytics lead | Strong Market Fit, Attendance Not Confirmed |
| Merck & Co., Inc. | Pharmaceutical company | Major R&D buyer for discovery biology, protein science, and assay platforms | merck.com | Director of R&D, procurement, scientific sourcing, platform lead | Strong Market Fit, Attendance Not Confirmed |
| Pfizer Inc. | Pharmaceutical company | Relevant buyer for life-science technologies, reagents, and research partnerships | pfizer.com | Scientific director, procurement, vendor manager, R&D operations | Strong Market Fit, Attendance Not Confirmed |
| Amgen Inc. | Biotechnology / pharma | Protein science, discovery biology, and translational workflows align with ASBMB themes | amgen.com | Lab head, strategic sourcing, purchasing, scientific operations | Strong Market Fit, Attendance Not Confirmed |
| Genentech | Biotechnology / pharma | Research-intensive buyer with high use of advanced molecular biology workflows | gene.com | Procurement, R&D operations, platform development, lab manager | Strong Market Fit, Attendance Not Confirmed |
| Thermo Fisher Scientific | Life science tools supplier / buyer and influencer | Attends as industry partner and has strong customer overlap; can influence downstream buyer ecosystems | thermofisher.com | Business development, partnerships, product management, field applications | Strong Market Fit, Attendance Not Confirmed |
| National Institutes of Health | Government research agency | Scientific funding, intramural research, and procurement influence | nih.gov | Program officer, contracting officer, lab director, grants specialist | Strong Market Fit, Attendance Not Confirmed |
| Broad lab / shared university core facilities network | Core facility buyer group | Purchases shared instrumentation, service contracts, and software for many end users | n/a | Core director, facility manager, operations manager, procurement | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Principal Investigator / Lab Director | Research | Director / VP / Faculty | Owns research direction and high-value scientific purchasing decisions. |
| 2 | Core Facility Director / Manager | Shared Research Infrastructure | Manager / Director | Influences procurement of shared instruments, service, and workflow tools. |
| 3 | Director of Research / R&D | Research & Development | Director / VP | Key decision-maker for platforms, vendors, and scientific partnerships. |
| 4 | Procurement Manager / Strategic Sourcing Manager | Procurement | Manager / Senior Manager | Controls supplier qualification, pricing, and contracts. |
| 5 | Research Operations / Lab Operations Manager | Operations | Manager / Director | Manages lab enablement, vendor service levels, and day-to-day workflow needs. |
| 6 | Biotech / Pharma Product Manager | Product / Marketing / R&D | Manager / Senior Manager | Evaluates scientific market needs and partner ecosystems. |
| 7 | Application Scientist / Field Application Specialist | Technical Support / Sales | Individual Contributor / Manager | Influences adoption, demos, and customer success in scientific tools. |
| 8 | Technology Transfer / Innovation Manager | Innovation / Commercialization | Manager / Director | Supports commercialization and partnership decisions. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Core attendee and exhibitor ecosystem aligned to molecular biosciences | R&D leaders, platform buyers, scientific directors |
| 2 | Pharmaceuticals | Strong translational and discovery research overlap | Procurement, R&D, scientific sourcing |
| 3 | Research | Academic and institutional science is a primary audience | PIs, lab directors, research administrators |
| 4 | Hospital & Health Care | Clinical research and translational science buyers attend such meetings | Research hospitals, clinical labs, procurement teams |
| 5 | Higher Education | Large concentration of faculty, labs, and shared facilities | Faculty, department administrators, procurement |
| 6 | Medical Devices | Relevant for analytical instruments, lab devices, and workflow hardware | Product managers, field application teams, channel partners |
| 7 | Biotechnology Research | Useful for data-driven outreach to R&D organizations | Lab operations, technology evaluation |
| 8 | Information Technology & Services | Scientific software, data platforms, and AI-driven research tools are increasingly relevant | IT directors, data leads, informatics teams |
| 9 | Information Services | Knowledge platforms, scientific content, and data services are relevant | Content, data, and informatics buyers |
| 10 | Chemicals | Reagents, assay inputs, and lab consumables ecosystem | Category managers, sourcing leads |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official website content provided does not disclose attendance volume | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | Official copy mentions exhibitions and sponsorship opportunities, but not count | Use official exhibitor list if published later. |
| Buyer count | Not publicly confirmed | Confirmed unavailable | No official buyer list provided in the supplied source text | Likely mixed academic, research, and industry attendees. |
| Speaker count | Not publicly confirmed | Confirmed unavailable | Official content names selected plenary/symposium speakers only | Useful for prospecting speaker institutions once agenda is finalized. |
| Historical attendance | Not included | Not used here | No verified prior-year attendance figure provided in the supplied source text | Avoids unsupported attendee-count claims. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Research instrumentation | Reliable platforms for protein, cell, and molecular biology workflows | Product demos, technical sessions, comparative performance discussions | Analytical instruments, microscopes, sequencers, imaging systems |
| Reagents and consumables | Dependable supply for ongoing experiments | Volume-based procurement and catalog onboarding | Antibodies, kits, buffers, cell culture, purification consumables |
| Proteomics and structural biology | Advanced discovery and validation workflows | Scientific education, application workflow design, partnership discussions | Mass spec, sample prep, data analysis software, protein engineering tools |
| AI and computation in biology | Faster interpretation, design, and data integration | Executive briefings, use-case demos, innovation sessions | AI-enabled research software, data platforms, workflow automation |
| Career development and training | Professional advancement and skill-building | Sponsored workshops, recruitment branding, education partnerships | Training programs, LMS, recruitment services, academic resources |
| Partnerships and sponsorships | Visibility in the scientific community | Lead capture, brand awareness, strategic alliances | Sponsored sessions, exhibit booths, branded content, affinity programs |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The audience contains research leaders, lab directors, core facilities, and industry R&D teams with real purchasing influence. |
| Decision-maker availability | High | Academic and industry scientific leaders are likely to be present, especially for networking and sponsor engagement. |
| Data collection potential | Medium | Useful for lead gen, but current-year attendee and exhibitor lists were not provided in the source text. |
| Apollo targeting potential | Very High | Strong fit for biotech, pharma, research, higher education, and hospital research decision-makers. |
| Geographic targeting potential | High | Boston adds a dense local life-science concentration and broader Northeast research corridor reach. |
| Best outreach approach | Scientific value-first outreach | Lead with research use cases, technical fit, and workflow outcomes rather than generic sponsorship language. |
| Overall lead quality | High | Strong event for scientific B2B lead generation, especially in life-science tools, services, and research software. |
| Best use case | Account targeting and exhibit/sponsor prospecting | Best used to target research institutions, biotech/pharma R&D, and scientific service buyers. |
| Limitations / risks | No confirmed current-year attendee list in source text | Requires post-announcement verification of exhibitors, speakers, and registered organizations for precise outreach. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Research; Higher Education; Hospital & Health Care; Medical Devices; Information Technology & Services; Chemicals | Capture the primary buyer universe for research, tools, and scientific services. |
| Departments | Research; Procurement; Operations; Product; R&D; IT; Lab Management; Facilities | Focus on groups with evaluation or budget authority. |
| Seniority | Manager; Senior Manager; Director; VP; CXO; Partner; Owner | Prioritize decision-makers and budget owners. |
| Job titles | PI, Lab Director, Core Facility Director, Procurement Manager, Strategic Sourcing Manager, Director of R&D, Research Operations Manager, Scientific Director, VP Research, Application Scientist | Align outreach to lab, research, and sourcing decision-makers. |
| Geography | United States; Northeast U.S.; Massachusetts; Boston metro; California; New York; New Jersey; Pennsylvania | Focus on Boston attendees and the major U.S. life-science corridor. |
| Employee size | 11-50; 51-200; 201-500; 501-1000; 1001-5000; 5001+ | Covers startups, mid-market biotech, and large enterprise buyers. |
| Keywords | molecular biology, proteomics, biochemistry, research, assay, protein science, core facility, translational, discovery, lab operations, bioinformatics | Refine by scientific application and workflow. |
| Company type | Academic institution; public company; private company; nonprofit research institute; hospital system; government agency | Capture the mixed buyer ecosystem of the event. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ASBMB Annual Meeting official page | Official organizer website | Event title, 2027 positioning, scientific purpose, program format, Boston context, organizers, and industry participation language | High |
| ASBMB main website | Official organizer website | Organizer identity and institutional scope in molecular life science | High |
| ASBMB Annual Meeting page - program and sponsorship sections | Official event website content | Industry-partner participation, meeting format, symposia, workshops, and networking structure | High |
| ASBMB Annual Meeting program page | Official agenda / program source | Scientific themes, plenary/symposium structure, and attendee content priorities | High |
| ASBMB Exhibits & Sponsorships page | Official sponsor/exhibitor source | Confirmed that the event has exhibition and strategic partnership participation opportunities | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Society for Biochemistry and Molecular Biology - ASBMB — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.